Question 1

What is the catalog number for HDGF Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)?

Accepted Answer

The catalog number for HDGF Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) is LV671157.

Question 2

Is HDGF Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) in stock?

Accepted Answer

HDGF Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

What happens if this product doesn’t perform as expected in my experiment?

Accepted Answer

Send us the catalogue number, product name, lot number, and a summary of your results. Our technical support team will investigate and, where needed, involve the manufacturer. This is covered under our guarantee provided the product was used before its expiry date and stored correctly.

Question 4

Is this product classed as hazardous or restricted for shipping?

Accepted Answer

Some products are subject to special import/export regulations, dangerous goods handling, or licensing requirements. Where this applies, it’s noted on the product page, and any required extra documents or fees will be confirmed with you before dispatch, never added without your consent.

Question 5

Can you help me confirm if this product is right for my specific experiment?

Accepted Answer

Yes, contact us with details of your sample type, species, and intended application, and our specialists will confirm suitability or suggest an alternative from our supplier network if this isn’t the best fit.

HDGF Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

Product Specifications

Frequently Asked Questions

Explore Other Products

Insulin (E2-E3), CF568 conjugate, 0.1mg/mL

Anti-SFXN5 Antibody Picoband®

CD19 (CVID3/429), CF568 conjugate, 0.1mg/mL

S100B (Astrocyte and Melanoma Marker), CF568 conjugate, 0.1mg/mL

ICOS-L / ICOS Ligand / B7RP-1 (Immuno-Oncology Target) (ICOSL/3260), CF568 conjugate, 0.1mg/mL

Anti-PGK1 Antibody Picoband® (APC Conjugate)